在初级保健中加强预先药物遗传 (PGx) 测试的整合:在实施中优先考虑欠缺服务的患者的偏好
Emma G Bryan1, Kelsey Lunsford2, Michaela D Mullis1
1Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
患者更喜欢积极主动,方便的药物遗传学 (PGx) 测试,以满足未来的健康需求. 他们重视从临床医生那里清楚地传达结果和药物信息,以优化治疗.
科学领域:
- 药物遗传学 药物遗传学
- 基因组医学是基因组医学.
- 实现初级保健的实施.
背景情况:
- 在初级保健中药物遗传学 (PGx) 测试的整合仍然有限.
- 通过优化药物处方,PGx测试有可能减少健康差异.
- 患者对PGx测试实施的偏好尚不清楚.
研究的目的:
- 为了捕捉患者对PGx测试的偏好,并在初级保健中传播结果.
- 为实施PGx测试提供信息,特别是在服务不足的人群中.
- 改进PGx测试的患者-临床医生互动和结果报告.
主要方法:
- 定性研究涉及25名初级保健患者的采访.
- 采访成绩单的专题分析,使用恒定的比较方法.
- 专注于患者对测试时间,结果讨论和信息传播的偏好.
主要成果:
- 患者喜欢预防性PGx测试,因为它具有主动性,方便性和加快效果.
- 处方时间的关键偏好包括立即访问,避免副作用和无效的治疗.
- 患者希望获得药物特定的信息,明确的结果解释和可访问的临床医生支持.
结论:
- 患者偏好对于在初级保健中成功实施PGx测试至关重要.
- 结果可以指导整合PGx测试的策略,特别是在服务不足的社区.
- 改善患者-临床医生沟通和结果清晰度对于采用至关重要.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
相关概念视频
Analysis of Population Pharmacokinetic Data
Preventive Healthcare Services
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
